In 2024, consumer health overall in Finland is seeing moderate value growth, primarily influenced by the ongoing economic challenges affecting specific segments such as basic OTC products. As a result, consumers are increasingly opting for generics and basic offerings. At the same time other categories, including vitamins and dietary supplements, digestive remedies, and sports nutrition, are performing more robustly.
Euromonitor International's Consumer Health in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Finland
Euromonitor International
September 2024
List Of Contents And Tables
CONSUMER HEALTH IN FINLAND
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Value sales decline for analgesics
Topical analgesics sees growth rise, while Orion Oyi maintains overall leadership
Paediatric analgesics continues to expand from a small base
PROSPECTS AND OPPORTUNITIES
Analgesics faces disappointing forecast period
Innovation to drive unit price growth
Smaller segments set to perform well
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Current value drops in 2024
Allergy care records positive growth, and Cloetta Suomi maintains leadership
Nasal sprays benefits from increased innovation
PROSPECTS AND OPPORTUNITIES
Moderate growth predicted for overall category
Combination products set to rise fastest
Rapid rises for nasal sprays and pharyngeal preparations
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Digestive remedies posts solid growth in 2024
Orion maintains overall category leadership
Digestive enzymes among strongest segments
PROSPECTS AND OPPORTUNITIES
Digestive remedies set to remain on positive growth trajectory
IBS treatments to rise rapidly as convenience trend accelerates
Solid growth predicted for digestive enzymes and H2 blockers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Scabies and new launches support growth in 2024
Bayer and Orion maintain leadership
Hair loss treatments sees improvement while nappy/rash treatments falls
PROSPECTS AND OPPORTUNITIES
Overall category set to expand slightly in terms of value sales
Antiparasitics and medicated shampoos anticipated to do well
Nappy(diaper) rash treatments will remain in decline
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sales slump as new regulations take effect
Highly consolidated competitive landscape
NRT sprays continues to rise in 2024, while Zonnic loses ground
PROSPECTS AND OPPORTUNITIES
Sales set to fall further during forecast period
Stricter regulations anticipated
Little room for value growth
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sleep aids see continued growth in 2024
Competition remains intense
Melatonin-based products become more prevalent
PROSPECTS AND OPPORTUNITIES
Sales set to slow down as competition intensifies
Melatonin and combination products will gather ground
Herbal variants likely to outpace standard alternatives
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Eye care sees positive growth in 2024
Bayer remains overall category leader
Allergy eye care goes from strength to strength
PROSPECTS AND OPPORTUNITIES
Continued though slowing growth forecast for eye care
Greater investment in innovation expected to cater to evolving demand
Allergy eye care still holds potential for substantial expansion, while ageing population supports sales in standard eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Value sales rise but growth is dampened by cost-consciousness
Orkla stays ahead, with players staying focused on innovation
Private label expands as consumers seek out value
PROSPECTS AND OPPORTUNITIES
Wound care to see strong growth
Private label sales will remain supported by consumers’ economic caution and rising trust
Value-added offerings set to become more prevalent
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Stagnant stales for vitamins in 2024
Orkla remains in the lead, followed by Orion, while multivitamins remains diverse
Innovation in terms of combination products and updated formats
PROSPECTS AND OPPORTUNITIES
Growth hampered by maturity
New recommendations may impact development, as other single vitamins strengthens
Fragmentation will increase and demand or value-added options will rise
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Current value sales rise in 2024
Fragmentation persists, while consumers seek out solutions to tackle high stress and low energy
Probiotics on the rise, while brain- and memory-targeted offerings see increased innovation
PROSPECTS AND OPPORTUNITIES
Value sales set to rise for dietary supplements
Probiotics will continue to expand
Mineral supplements to benefit from iron’s popularity as convenience trend impacts format development
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Category decline persists in 2024
Nutricia and Nutrilett head up brands
Decline driven by waning consumer interest
PROSPECTS AND OPPORTUNITIES
Category faces continued struggle ahead
Competition from other categories will have further hamper growth
Stagnation for small segments suffering lack of development
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sports nutrition forges ahead in 2024
Leader foods leads sports nutrition, followed by Celsius Finland
Sports non-protein products leads category growth, with candy format attracting attention
PROSPECTS AND OPPORTUNITIES
Sports nutrition faces bright future
Non-protein variants to see fastest growth
Sports RTD will rise strongly, while more products for those on the go will enter the overall category
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Natural trend supports category growth in 2024
Cloetta Suomi leads highly fragmented competitive landscape
Topical analgesics and sleep aids benefit from rising consumer interest
PROSPECTS AND OPPORTUNITIES
Herbal/traditional products to maintain positive growth
Rising sales for topical analgesics and stress relievers
Sleep aids holds potential for further expansion
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN FINLAND
KEY DATA FINDINGS
2024 DEVELOPMENTS
Robust growth driven by immature subcategories
GSK Consumer Healthcare maintains overall leadership in 2024
Solid growth seen in several segments
PROSPECTS AND OPPORTUNITIES
Growth will remain positive but hampered by negative birth rates
Vitamins and dietary supplements among fastest risers
While nappy (diaper) rash treatments will fall, overall category holds potential for expansion
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029